{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T21:20:33Z","timestamp":1778620833219,"version":"3.51.4"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82000073"],"award-info":[{"award-number":["82000073"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.intimp.2022.109316","type":"journal-article","created":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T20:45:29Z","timestamp":1665780329000},"page":"109316","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"PA","title":["Zanubrutinib attenuates bleomycin-induced pulmonary fibrosis by inhibiting the TGF-\u03b21 signaling pathway"],"prefix":"10.1016","volume":"113","author":[{"given":"Shanshan","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuli","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shimeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinying","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunyao","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhichao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingjing","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luqing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohe","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Honggang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.intimp.2022.109316_b0005","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1080\/17476348.2018.1462704","article-title":"Lung transplantation in idiopathic pulmonary fibrosis","volume":"12","author":"Kumar","year":"2018","journal-title":"Expert Rev. Respir. Med."},{"issue":"10082","key":"10.1016\/j.intimp.2022.109316_b0010","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/S0140-6736(17)30866-8","article-title":"Idiopathic pulmonary fibrosis","volume":"389","author":"Richeldi","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2022.109316_b0015","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.pupt.2016.07.009","article-title":"Pirfenidone, nintedanib and N-acetylcysteine for the treatment of idiopathic pulmonary fibrosis: A systematic review and meta-analysis","volume":"40","author":"Rogliani","year":"2016","journal-title":"Pulm. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.intimp.2022.109316_b0020","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.amjms.2019.02.008","article-title":"The Aging Lung and Idiopathic Pulmonary Fibrosis","volume":"357","author":"Gulati","year":"2019","journal-title":"Am. J. Med. Sci."},{"issue":"10","key":"10.1016\/j.intimp.2022.109316_b0025","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1080\/17476348.2018.1513332","article-title":"Novel management strategies for idiopathic pulmonary fibrosis","volume":"12","author":"Ahmad","year":"2018","journal-title":"Expert Rev. Respir. Med."},{"issue":"3","key":"10.1016\/j.intimp.2022.109316_b0030","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/modpathol.2011.166","article-title":"The distribution of immunomodulatory cells in the lungs of patients with idiopathic pulmonary fibrosis","volume":"25","author":"Nuovo","year":"2012","journal-title":"Mod. Pathol."},{"issue":"5","key":"10.1016\/j.intimp.2022.109316_b0035","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.4049\/jimmunol.1203476","article-title":"Plasma B lymphocyte stimulator and B cell differentiation in idiopathic pulmonary fibrosis patients","volume":"191","author":"Xue","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2022.109316_b0040","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.rmed.2018.12.015","article-title":"Inflammation and immunity in IPF pathogenesis and treatment","volume":"147","author":"Heukels","year":"2019","journal-title":"Respir. Med."},{"issue":"10","key":"10.1016\/j.intimp.2022.109316_b0045","doi-asserted-by":"crossref","first-page":"5735","DOI":"10.4049\/jimmunol.176.10.5735","article-title":"Cutting edge: nonproliferating mature immune cells form a novel type of organized lymphoid structure in idiopathic pulmonary fibrosis","volume":"176","author":"Marchal-Somme","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2022.109316_b0050","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2147\/JIR.S40673","article-title":"Lymphocyte aggregates persist and accumulate in the lungs of patients with idiopathic pulmonary fibrosis","volume":"6","author":"Todd","year":"2013","journal-title":"J. Inflamm. Res."},{"issue":"6","key":"10.1016\/j.intimp.2022.109316_b0055","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1165\/rcmb.2020-0387OC","article-title":"Antifibrotics Modify B-Cell-induced Fibroblast Migration and Activation in Patients with Idiopathic Pulmonary Fibrosis","volume":"64","author":"Ali","year":"2021","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"1","key":"10.1016\/j.intimp.2022.109316_b0060","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s12931-019-1195-7","article-title":"Enhanced Bruton's tyrosine kinase in B-cells and autoreactive IgA in patients with idiopathic pulmonary fibrosis","volume":"20","author":"Heukels","year":"2019","journal-title":"Respir. Res."},{"issue":"9","key":"10.1016\/j.intimp.2022.109316_b0065","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1002\/emmm.201100604","article-title":"Genetic partitioning of interleukin-6 signalling in mice dissociates Stat3 from Smad3-mediated lung fibrosis","volume":"4","author":"O'Donoghue","year":"2012","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.intimp.2022.109316_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113329","article-title":"Emerging small-molecule inhibitors of the Bruton's tyrosine kinase (BTK): Current development","volume":"217","author":"Liu","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.intimp.2022.109316_b0075","doi-asserted-by":"crossref","first-page":"46560","DOI":"10.1038\/srep46560","article-title":"The peripheral blood proteome signature of idiopathic pulmonary fibrosis is distinct from normal and is associated with novel immunological processes","volume":"7","author":"O'Dwyer","year":"2017","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.intimp.2022.109316_b0080","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1007\/s10753-018-0745-3","article-title":"Ibrutinib Exacerbates Bleomycin-Induced Pulmonary Fibrosis via Promoting Inflammation","volume":"41","author":"Gu","year":"2018","journal-title":"Inflammation."},{"issue":"2","key":"10.1016\/j.intimp.2022.109316_b0085","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/cmdc.201900606","article-title":"Novel Pyrimidines as Multitarget Protein Tyrosine Kinase Inhibitors for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)","volume":"15","author":"Sun","year":"2020","journal-title":"ChemMedChem"},{"issue":"1","key":"10.1016\/j.intimp.2022.109316_b0090","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12943-018-0779-z","article-title":"Role of Bruton's tyrosine kinase in B cells and malignancies","volume":"17","author":"Pal Singh","year":"2018","journal-title":"Mol. Cancer"},{"issue":"16","key":"10.1016\/j.intimp.2022.109316_b0095","doi-asserted-by":"crossref","first-page":"4216","DOI":"10.1158\/1078-0432.CCR-19-3703","article-title":"Treatment of Patients with Relapsed or Refractory Mantle-Cell Lymphoma with Zanubrutinib, a Selective Inhibitor of Bruton's Tyrosine Kinase","volume":"26","author":"Song","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.intimp.2022.109316_b0100","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1080\/17474086.2020.1851184","article-title":"Zanubrutinib for the treatment of Waldenstrom Macroglobulinemia","volume":"13","author":"Lim","year":"2020","journal-title":"Expert Rev. Hematol."},{"issue":"5","key":"10.1016\/j.intimp.2022.109316_b0105","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1165\/rcmb.2017-0096ST","article-title":"An Official American Thoracic Society Workshop Report: Use of Animal Models for the Preclinical Assessment of Potential Therapies for Pulmonary Fibrosis","volume":"56","author":"Jenkins","year":"2017","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"2","key":"10.1016\/j.intimp.2022.109316_b0110","doi-asserted-by":"crossref","first-page":"L313","DOI":"10.1152\/ajplung.00033.2017","article-title":"Surfactant replacement therapy reduces acute lung injury and collapse induration-related lung remodeling in the bleomycin model","volume":"313","author":"Steffen","year":"2017","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"issue":"6","key":"10.1016\/j.intimp.2022.109316_b0115","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01105-2019","article-title":"The importance of interventional timing in the bleomycin model of pulmonary fibrosis","volume":"55","author":"Kolb","year":"2020","journal-title":"Eur. Respir. J."},{"issue":"8","key":"10.1016\/j.intimp.2022.109316_b0120","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1164\/rccm.201201-0084OC","article-title":"Lactic acid is elevated in idiopathic pulmonary fibrosis and induces myofibroblast differentiation via pH-dependent activation of transforming growth factor-beta","volume":"186","author":"Kottmann","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"6","key":"10.1016\/j.intimp.2022.109316_b0125","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1083\/jcb.200704042","article-title":"Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix","volume":"179","author":"Wipff","year":"2007","journal-title":"J. Cell Biol."},{"issue":"2","key":"10.1016\/j.intimp.2022.109316_b0130","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jdermsci.2003.12.006","article-title":"TGF-beta-induced SMAD signaling and gene regulation: consequences for extracellular matrix remodeling and wound healing","volume":"35","author":"Schiller","year":"2004","journal-title":"J. Dermatol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2022.109316_b0135","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cell.2007.12.018","article-title":"Autophagy in the pathogenesis of disease","volume":"132","author":"Levine","year":"2008","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.intimp.2022.109316_b0140","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.febslet.2010.01.017","article-title":"mTOR regulation of autophagy","volume":"584","author":"Jung","year":"2010","journal-title":"FEBS Lett."},{"issue":"1","key":"10.1016\/j.intimp.2022.109316_b0145","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41467-018-07858-8","article-title":"The mTORC1\/4E-BP1 axis represents a critical signaling node during fibrogenesis","volume":"10","author":"Woodcock","year":"2019","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.intimp.2022.109316_b0150","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ceb.2008.05.002","article-title":"Extracellular matrix regulation of autophagy","volume":"20","author":"Lock","year":"2008","journal-title":"Curr. Opin. Cell Biol."},{"issue":"2","key":"10.1016\/j.intimp.2022.109316_b0155","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00441-015-2262-0","article-title":"Soluble epoxide hydrolase inhibitor 1-trifluoromethoxyphenyl-3- (1-propionylpiperidin-4-yl) urea attenuates bleomycin-induced pulmonary fibrosis in mice","volume":"363","author":"Zhou","year":"2016","journal-title":"Cell Tissue Res."},{"issue":"41","key":"10.1016\/j.intimp.2022.109316_b0160","doi-asserted-by":"crossref","first-page":"14895","DOI":"10.1073\/pnas.0401168101","article-title":"Comprehensive gene expression profiles reveal pathways related to the pathogenesis of chronic obstructive pulmonary disease","volume":"101","author":"Ning","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.intimp.2022.109316_b0165","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22041985","article-title":"Regorafenib-Attenuated, Bleomycin-Induced Pulmonary Fibrosis by Inhibiting the TGF-beta1 Signaling Pathway","volume":"22","author":"Li","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2022.109316_b0170","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3389\/fphar.2019.01021","article-title":"Antifibrotic Mechanism of Cinobufagin in Bleomycin-Induced Pulmonary Fibrosis in Mice","volume":"10","author":"Li","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2022.109316_b0175","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1172\/JCI16861","article-title":"Regulation of pulmonary fibrosis by chemokine receptor CXCR3","volume":"114","author":"Jiang","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2022.109316_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107839","article-title":"Therapeutic targets in lung tissue remodelling and fibrosis","volume":"225","author":"Liu","year":"2021","journal-title":"Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.intimp.2022.109316_b0185","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01346-2019","article-title":"TRIM33 prevents pulmonary fibrosis by impairing TGF-beta1 signalling","volume":"55","author":"Boutanquoi","year":"2020","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.intimp.2022.109316_b0190","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cca.2019.12.016","article-title":"Autophagy, an important therapeutic target for pulmonary fibrosis diseases","volume":"502","author":"Zhao","year":"2020","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"10.1016\/j.intimp.2022.109316_b0195","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1172\/JCI73939","article-title":"mTOR: a pharmacologic target for autophagy regulation","volume":"125","author":"Kim","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.intimp.2022.109316_b0200","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12931-020-1319-0","article-title":"TGF-beta pathway activation by idiopathic pulmonary fibrosis (IPF) fibroblast derived soluble factors is mediated by IL-6 trans-signaling","volume":"21","author":"Epstein Shochet","year":"2020","journal-title":"Respir. Res."},{"issue":"Suppl 14","key":"10.1016\/j.intimp.2022.109316_b0205","doi-asserted-by":"crossref","first-page":"S1740","DOI":"10.21037\/jtd.2019.04.62","article-title":"Pharmacotherapy and adjunctive treatment for idiopathic pulmonary fibrosis (IPF)","volume":"11","author":"Saito","year":"2019","journal-title":"J. Thorac. Dis."},{"issue":"6","key":"10.1016\/j.intimp.2022.109316_b0210","doi-asserted-by":"crossref","DOI":"10.3390\/cells10061321","article-title":"Aberrant B Cell Receptor Signaling in Naive B Cells from Patients with Idiopathic Pulmonary Fibrosis","volume":"10","author":"Neys","year":"2021","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.intimp.2022.109316_b0215","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrc3702","article-title":"Targeting Bruton's tyrosine kinase in B cell malignancies","volume":"14","author":"Hendriks","year":"2014","journal-title":"Nat. Rev. Cancer"},{"issue":"17","key":"10.1016\/j.intimp.2022.109316_b0220","doi-asserted-by":"crossref","first-page":"7923","DOI":"10.1021\/acs.jmedchem.9b00687","article-title":"Discovery of Zanubrutinib (BGB-3111), a Novel, Potent, and Selective Covalent Inhibitor of Bruton's Tyrosine Kinase","volume":"62","author":"Guo","year":"2019","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.intimp.2022.109316_b0225","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1002\/sctm.20-0068","article-title":"Amniotic MSCs reduce pulmonary fibrosis by hampering lung B-cell recruitment, retention, and maturation","volume":"9","author":"Cargnoni","year":"2020","journal-title":"Stem Cells Transl. Med."},{"issue":"19","key":"10.1016\/j.intimp.2022.109316_b0230","doi-asserted-by":"crossref","first-page":"4416","DOI":"10.1111\/bph.15182","article-title":"Inhibition of Bruton's TK regulates macrophage NF-kappaB and NLRP3 inflammasome activation in metabolic inflammation","volume":"177","author":"Purvis","year":"2020","journal-title":"Br. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.intimp.2022.109316_b0235","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1158\/0008-5472.CAN-14-2852","article-title":"Ibrutinib exerts potent antifibrotic and antitumor activities in mouse models of pancreatic adenocarcinoma","volume":"75","author":"Masso-Valles","year":"2015","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.intimp.2022.109316_b0240","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.intimp.2022.109316_b0245","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00006676-199707000-00002","article-title":"Diagnostic criteria for chronic pancreatitis by the Japan Pancreas Society","volume":"15","author":"Homma","year":"1997","journal-title":"Pancreas"},{"issue":"12","key":"10.1016\/j.intimp.2022.109316_b0250","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18122527","article-title":"Role of MicroRNAs in TGF-beta Signaling Pathway-Mediated Pulmonary Fibrosis","volume":"18","author":"Kang","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2022.109316_b0255","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.matbio.2017.12.009","article-title":"Thrombospondin-1 regulation of latent TGF-beta activation: A therapeutic target for fibrotic disease","volume":"68\u201369","author":"Murphy-Ullrich","year":"2018","journal-title":"Matrix Biol."},{"issue":"4","key":"10.1016\/j.intimp.2022.109316_b0260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094616","article-title":"IPF fibroblasts are desensitized to type I collagen matrix-induced cell death by suppressing low autophagy via aberrant Akt\/mTOR kinases","volume":"9","author":"Nho","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.intimp.2022.109316_b0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.matbio.2022.08.010","article-title":"Loss of BTK ameliorates the pathological cardiac fibrosis and dysfunction","author":"Wang","year":"2022","journal-title":"Matrix Biol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922008001?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922008001?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:55:47Z","timestamp":1778619347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576922008001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":53,"alternative-id":["S1567576922008001"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2022.109316","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Zanubrutinib attenuates bleomycin-induced pulmonary fibrosis by inhibiting the TGF-\u03b21 signaling pathway","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2022.109316","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109316"}}